Since our last article discussing Kintara Therapeutics (NASDAQ: KTRA) underappreciated value proposition to investors, CEO Saiid Zarrabian has solidified the company’s position for growth in 2021 and … [Read more...] about Kintara Therapeutcis (NASDAQ: KTRA)….
gbm agile
DelMar Pharmaceuticals (NASDAQ: DMPI): A New Beginning
For the past 6-months our team at MS Money Moves has been following the story of DelMar Pharmaceuticals (NASDAQ: DMPI) in an effort to educate and inform the investment community. During this time, we … [Read more...] about DelMar Pharmaceuticals (NASDAQ: DMPI): A New Beginning
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Portuguese
Russian
Spanish
You must be logged in to post a comment.